{"id":"https://openalex.org/W4301227643","doi":"https://doi.org/10.17615/e4n2-eg13","title":"Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia","display_name":"Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia","publication_year":2021,"publication_date":"2021-07-03","ids":{"openalex":"https://openalex.org/W4301227643","doi":"https://doi.org/10.17615/e4n2-eg13"},"language":"en","primary_location":{"id":"pmh:cdr.lib.unc.edu:nk322q089","doi":null,"is_oa":true,"landing_page_url":"https://cdr.lib.unc.edu/downloads/g732dk11n","pdf_url":"https://cdr.lib.unc.edu/downloads/g732dk11n","source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The New England Journal of Medicine, 353(12)","raw_type":"Article"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://cdr.lib.unc.edu/downloads/g732dk11n","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027752754","display_name":"Robert Alan Rosenheck","orcid":"https://orcid.org/0000-0003-4314-4592","observed_orcids":["https://orcid.org/0000-0003-4314-4592"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosenheck, Robert A.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109121499","display_name":"Joseph P. McEvoy","orcid":"https://orcid.org/0000-0002-0047-5124","observed_orcids":["https://orcid.org/0000-0002-0047-5124"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"McEvoy, Joseph P.","raw_affiliation_strings":["School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108243598","display_name":"Joanne B. Severe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Severe, Joanne","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053223016","display_name":"Barry D. Lebowitz","orcid":"https://orcid.org/0000-0002-6467-646X","observed_orcids":["https://orcid.org/0000-0002-6467-646X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lebowitz, Barry D.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023756758","display_name":"T. Scott Stroup","orcid":"https://orcid.org/0000-0002-3123-0672","observed_orcids":["https://orcid.org/0000-0002-3123-0672"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Stroup, T.","raw_affiliation_strings":["University of North Carolina at Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075093461","display_name":"Jeffrey Alan Lieberman","orcid":"https://orcid.org/0000-0002-1899-1776","observed_orcids":["https://orcid.org/0000-0002-1899-1776"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lieberman, Jeffrey A.","raw_affiliation_strings":["School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026643447","display_name":"Richard S.E. Keefe","orcid":"https://orcid.org/0000-0002-0173-8897","observed_orcids":["https://orcid.org/0000-0002-0173-8897"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keefe, Richard S.E.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109940472","display_name":"CLARENCE E. DAVIS","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Davis, Clarence E.","raw_affiliation_strings":["University of North Carolina at Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036507830","display_name":"John Hsiao","orcid":"https://orcid.org/0000-0003-3471-7539","observed_orcids":["https://orcid.org/0000-0003-3471-7539"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hsiao, John K.","raw_affiliation_strings":["University of North Carolina at Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041019143","display_name":"Sonia Thomas","orcid":"https://orcid.org/0000-0003-1362-5627","observed_orcids":["https://orcid.org/0000-0003-1362-5627"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Davis, Sonia M.","raw_affiliation_strings":["University of North Carolina at Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103323158","display_name":"Marvin S. Swartz","orcid":"https://orcid.org/0000-0002-1111-9299","observed_orcids":["https://orcid.org/0000-0002-1111-9299"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Swartz, Marvin S.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5005838731","display_name":"Diana O. Perkins","orcid":"https://orcid.org/0000-0001-9396-2206","observed_orcids":["https://orcid.org/0000-0001-9396-2206"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Perkins, Diana O.","raw_affiliation_strings":["University of North Carolina at Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1793,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.54865796,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-schizophrenia","display_name":"chronic schizophrenia","score":0.843999981880188},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8309999704360962},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8759999871253967},{"id":"https://openalex.org/keywords/typical-antipsychotics","display_name":"typical antipsychotics","score":0.9139999747276306},{"id":"https://openalex.org/keywords/perphenazine","display_name":"perphenazine","score":0.859000027179718},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":1.0},{"id":"https://openalex.org/keywords/ziprasidone","display_name":"ziprasidone","score":1.0},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.9649999737739563},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.621999979019165},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.7649999856948853},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.9179999828338623},{"id":"https://openalex.org/keywords/metabolic-side-effects","display_name":"metabolic side effects","score":0.8069999814033508},{"id":"https://openalex.org/keywords/comparative-efficacy","display_name":"drug efficacy comparison","score":0.4429999887943268},{"id":"https://openalex.org/keywords/long-term-treatment-outcomes","display_name":"long-term treatment outcomes","score":0.5320000052452087}],"concepts":[{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7801198959350586},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7167238593101501},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5394578576087952},{"id":"https://openalex.org/C3019878999","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic drug","level":4,"score":0.5085150003433228},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4592755436897278},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3924880623817444}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:cdr.lib.unc.edu:nk322q089","doi":null,"is_oa":true,"landing_page_url":"https://cdr.lib.unc.edu/downloads/g732dk11n","pdf_url":"https://cdr.lib.unc.edu/downloads/g732dk11n","source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The New England Journal of Medicine, 353(12)","raw_type":"Article"},{"id":"doi:10.17615/e4n2-eg13","doi":"https://doi.org/10.17615/e4n2-eg13","is_oa":true,"landing_page_url":"https://doi.org/10.17615/e4n2-eg13","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"pmh:cdr.lib.unc.edu:nk322q089","doi":null,"is_oa":true,"landing_page_url":"https://cdr.lib.unc.edu/downloads/g732dk11n","pdf_url":"https://cdr.lib.unc.edu/downloads/g732dk11n","source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The New England Journal of Medicine, 353(12)","raw_type":"Article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G1121004391","display_name":null,"funder_award_id":"N01 MH90001","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G8700482840","display_name":null,"funder_award_id":"MH90001","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320310281","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666"},{"id":"https://openalex.org/F4320318439","display_name":"Foundation of Hope for Research and Treatment of Mental Illness","ror":"https://ror.org/036brtn72"},{"id":"https://openalex.org/F4320324177","display_name":"Otsuka Pharmaceutical","ror":"https://ror.org/013k5y296"},{"id":"https://openalex.org/F4320332600","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"},{"id":"https://openalex.org/F4320337601","display_name":"Janssen Pharmaceuticals","ror":"https://ror.org/03qd7mz70"},{"id":"https://openalex.org/F4320337683","display_name":"School of Medicine, University of North Carolina at Chapel Hill","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4301227643.pdf","grobid_xml":"https://content.openalex.org/works/W4301227643.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2180693160","https://openalex.org/W2070427088","https://openalex.org/W4251718241","https://openalex.org/W1968926095","https://openalex.org/W2081978467","https://openalex.org/W2040915057","https://openalex.org/W2159039084","https://openalex.org/W1998036667","https://openalex.org/W2778679426","https://openalex.org/W2092965321"],"abstract_inverted_index":{"BACKGROUND":[0],"The":[1,114,189,225,267],"relative":[2],"effectiveness":[3,124],"of":[4,13,46,125,133,143,155,162,169,176,184,194,230,269,296,299,304,314,330],"second-generation":[5],"(atypical)":[6],"antipsychotic":[7,307],"drugs":[8,38],"as":[9],"compared":[10,30],"with":[11,35,49,247,260,322],"that":[12,313],"older":[14],"agents":[15,22],"has":[16],"been":[17],"incompletely":[18],"addressed,":[19],"though":[20],"newer":[21,37],"are":[23],"currently":[24],"used":[25],"far":[26],"more":[27,248,261],"commonly.":[28],"We":[29],"a":[31,40],"first-generation":[32],"antipsychotic,":[33],"perphenazine,":[34,166],"several":[36],"in":[39,121,202,207,217,271,294,328],"double-blind":[41],"study.":[42],"METHODS":[43],"A":[44],"total":[45],"1493":[47],"patients":[48,134,146,270],"schizophrenia":[50],"were":[51,234],"recruited":[52],"at":[53,149],"57":[54],"U.S.":[55],"sites":[56],"and":[57,111,181,256,301,317,326,332],"randomly":[58],"assigned":[59,157,164,171,178,186,276],"to":[60,64,71,78,86,93,98,118,158,165,172,179,187,191,227,279,312],"receive":[61],"olanzapine":[62,204,244],"(7.5":[63],"30":[65],"mg":[66,73,80,88,100],"per":[67,74,81,89,101],"day),":[68,75,82],"perphenazine":[69,219,257,309],"(8":[70],"32":[72],"quetiapine":[76,209],"(200":[77],"800":[79],"or":[83,211,221,253,281,285],"risperidone":[84,212],"(1.5":[85],"6.0":[87],"day)":[90,102],"for":[91,196,250,263,286],"up":[92],"18":[94,140],"months.":[95],"Ziprasidone":[96],"(40":[97],"160":[99],"was":[103,117,199,245,258,290,320],"included":[104],"after":[105],"its":[106],"approval":[107],"by":[108],"the":[109,122,136,144,192,203,208,218,237,240,291,297,302,305],"Food":[110],"Drug":[112],"Administration.":[113],"primary":[115],"aim":[116],"delineate":[119],"differences":[120],"overall":[123],"these":[126],"five":[127],"treatments.":[128],"RESULTS":[129],"Overall,":[130],"74":[131,174],"percent":[132,154,161,168,175,183],"discontinued":[135,274],"study":[137],"medication":[138],"before":[139],"months":[141],"(1061":[142],"1432":[145],"who":[147],"received":[148],"least":[150],"one":[151],"dose):":[152],"64":[153],"those":[156,163,170,177,185],"olanzapine,":[159],"75":[160],"82":[167],"quetiapine,":[173,315],"risperidone,":[180,316],"79":[182],"ziprasidone.":[188,318],"time":[190],"discontinuation":[193,228,249,262],"treatment":[195,277],"any":[197],"cause":[198],"significantly":[200],"longer":[201],"group":[205,273],"than":[206],"(P<0.001)":[210],"(P=0.002)":[213],"group,":[214],"but":[215,239],"not":[216],"(P=0.021)":[220],"ziprasidone":[222],"(P=0.028)":[223],"group.":[224],"times":[226],"because":[229],"intolerable":[231,282],"side":[232,283],"effects":[233,284],"similar":[235,311],"among":[236],"groups,":[238],"rates":[241,298],"differed":[242],"(P=0.04);":[243],"associated":[246,259,321],"weight":[251,324],"gain":[252,325],"metabolic":[254],"effects,":[255],"extrapyramidal":[264],"effects.":[265],"CONCLUSIONS":[266],"majority":[268],"each":[272],"their":[275],"owing":[278],"inefficacy":[280],"other":[287],"reasons.":[288],"Olanzapine":[289,319],"most":[292],"effective":[293],"terms":[295],"discontinuation,":[300],"efficacy":[303],"conventional":[306],"agent":[308],"appeared":[310],"greater":[323],"increases":[327],"measures":[329],"glucose":[331],"lipid":[333],"metabolism.":[334]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2022-10-05T00:00:00"}